Risk of herpes zoster and postherpetic neuralgia in patients with psoriasis treated with biologics: a nationwide study using a target trial emulation framework
Our findings suggest that ustekinumab and guselkumab may be associated with a reduced risk of HZ and PHN vs. TSTs in patients with psoriasis. This study could have significance for real-world practice.
Authors
- Chi‐Hau Chen (ORCID: https://orcid.org/0000-0003-4903-7878)
- Miyuki Hsing‐Chun Hsieh (ORCID: https://orcid.org/0000-0002-7995-7408)
- Chaw‐Ning Lee (ORCID: https://orcid.org/0000-0002-0848-0657)
- Tzu-Chi Liao
- Edward Chia‐Cheng Lai (ORCID: https://orcid.org/0000-0002-5852-7652)
- Chao‐Chun Yang (ORCID: https://orcid.org/0000-0002-3897-6522)
Institutions
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1093/bjd/ljaf101
- Citations
- 2
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 3.34